Scientific article
Open access

Faut-il dépister et traiter l'hypothyroïdie infraclinique?

Other titleShould we screen and treat subclinical hypothyroidism?
Published inRevue médicale suisse, vol. 8, no. 331, p. 501-502,504-6
Publication date2012-03-07

Subclinical hypothyroidism, defined as an elevated thyroid stimulating hormone and normal thyroxine level, is common with aging, particularly after 65 years old. This condition is potentially associated with important consequences, such as cardiovascular diseases and cognitive disorders. So far, indications for screening and thyroxine replacement therapy are still controversial. In this review, we examine the data on those risks and the potential benefits of the treatment. We also present a large European randomized clinical trial that should clarify this controversy, in order to improve clinical care of patients with subclinical hypothyroidism and to give reliable data on maintaining good health among the elderly.

  • Humans
  • Hypothyroidism / diagnosis
  • Hypothyroidism / therapy
  • Practice Guidelines as Topic
Research group
Citation (ISO format)
VIRGINI, Vanessa et al. Faut-il dépister et traiter l’hypothyroïdie infraclinique? In: Revue médicale suisse, 2012, vol. 8, n° 331, p. 501–502,504–6.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation04/02/2022 5:42:00 AM
First validation04/02/2022 5:42:00 AM
Update time03/16/2023 10:48:32 AM
Status update03/16/2023 10:48:32 AM
Last indexation01/17/2024 11:06:09 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack